Exposure to myeloma cell lysates affects the immune competence of dendritic cells and favors the induction of Tr1-like regulatory T cells

被引:40
作者
Fiore, F
Nuschak, B
Peola, S
Mariani, S
Muraro, M
Foglietta, M
Coscia, M
Bruno, B
Boccadoro, M
Massaia, M
机构
[1] Univ Turin, Div Ematol, I-10126 Turin, Italy
[2] Osped San Giovanni Battista Torino, Ctr Ric Med Sperimentale, Lab Ematol Oncol, Turin, Italy
关键词
dendritic cells; myeloma; tumor lysates; anti-tumor immunity;
D O I
10.1002/eji.200425093
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The aim of this work was to investigate the interactions of tumor cells with dendritic cells (DC) in normal donors and patients with multiple myeloma (MM). Normal and MM DC internalized necrotic lysates derived from myeloma cell lines (MCL) with high efficiency, whereas necrotic lysates from primary myeloma cells (PMC) were internalized with significantly lower efficiency. A positive correlation was found between susceptibility to internalization and the ability to induce DC maturation. After PMC exposure, DC produced large amounts of IL-10 and measurable amounts of IL-4 but no detectable IL-12. Two rounds of exposure to PMC-treated DC generated autologous T cells with low proliferative capacity, decreased IFN-gamma production and increased IL-10 production in the absence of IL-4 production. These data indicate that myeloma cells can affect host immunity by priming DC towards a maturation state favoring the generation of T cells with a regulatory rather than an effector phenotype.
引用
收藏
页码:1155 / 1163
页数:9
相关论文
共 40 条
  • [1] Almand B, 2000, CLIN CANCER RES, V6, P1755
  • [2] Dendritic cells as vectors for therapy
    Banchereau, J
    Schuler-Thurner, B
    Palucka, AK
    Schuler, G
    [J]. CELL, 2001, 106 (03) : 271 - 274
  • [3] Bausinger H, 2002, EUR J IMMUNOL, V32, P3708, DOI 10.1002/1521-4141(200212)32:12<3708::AID-IMMU3708>3.0.CO
  • [4] 2-C
  • [5] Different efficiency of heat shock proteins (HSP) to activate human monocytes and dendritic cells: Superiority of HSP60
    Bethke, K
    Staib, F
    Distler, M
    Schmitt, U
    Jonuleit, H
    Enk, AH
    Galle, PR
    Heike, M
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 169 (11) : 6141 - 6148
  • [6] Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1 and 2 cell development: Dependency on antigen dose and differential toll-like receptor ligation
    Boonstra, A
    Asselin-Paturel, C
    Gilliet, M
    Crain, C
    Trinchieri, G
    Liu, YJ
    O'Garra, A
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (01) : 101 - 109
  • [7] Dynamics of CD8+ T cell priming by dendritic cells in intact lymph nodes
    Bousso, P
    Robey, E
    [J]. NATURE IMMUNOLOGY, 2003, 4 (06) : 579 - 585
  • [8] Molecular monitoring of minimal residual disease in patients in long-term complete remission after allogeneic stem cell transplantation for multiple myeloma
    Cavo, M
    Terragna, C
    Martinelli, G
    Ronconi, S
    Zamagni, E
    Tosi, P
    Lemoli, RM
    Benni, M
    Pagliani, G
    Bandini, G
    Tura, S
    [J]. BLOOD, 2000, 96 (01) : 355 - +
  • [9] Monocyte-derived CD1a+ and CD1a- dendritic cell subsets differ in their cytokine production profiles, susceptibilities to transfection, and capacities to direct Th cell differentiation
    Chang, CCJ
    Wright, A
    Punnonen, J
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 165 (07) : 3584 - 3591
  • [10] HIGH-DOSE SEQUENTIAL CHEMORADIOTHERAPY IN MULTIPLE-MYELOMA - RESIDUAL TUMOR-CELLS ARE DETECTABLE IN BONE-MARROW AND PERIPHERAL-BLOOD CELL HARVESTS AND AFTER AUTOGRAFTING
    CORRADINI, P
    VOENA, C
    ASTOLFI, M
    LADETTO, M
    TARELLA, C
    BOCCADORO, M
    PILERI, A
    [J]. BLOOD, 1995, 85 (06) : 1596 - 1602